Indeed, clinical studies correlate high leptin levels [17], [21]–[23] and low adiponectin levels in women to an increased risk of breast cancer [11], [17], [22], [23], metastatic tumor phenotype [24] with poor prognosis [25], [26]. Here, ADIPOQ is linked to breast carcinoma.